13th Aug 2019 – The global high
throughput screening (HTS) market size is anticipated to value at USD
30.91 billion by 2025, during the forecast period. HTS market is subject to
show a substantial growth due to the growing emphasis on drug discovery and
development coupled with increasing investment by governmental agencies and
research institutes. With recent advancement in technology and growing need for
automation for liquid handling, formation of innovative platforms, and
improvements in existing analytical tools allows to handle large sets of data,
thus driving growth of the high throughput screening (HTS) market
exponentially. Furthermore, rising competition between various healthcare and
pharmaceutical organizations to revolutionize drug discovery is catering to the
growth of the HTS market in coming years.
Constant demand for high throughput
screening (HTS) in research and production areas is further propelling growth
of the HTS market. Globally, the high throughput screening (HTS) market is
predicted to grow at CAGR of 7.89% in forecast period, providing numerous
opportunity for market players to invest for research and development in the
HTS market. High throughput screening, commonly referred as a high content
screening (HCS), majorly adopted to carry out various genetic, biochemical, and
pharmacology studies to help in the drug discovery procedure involving drug
design to medicine trails and analysis of the effects caused by drug
interactions. High throughput screening (HTS) procedure consists of high-tech
software, numerous instruments to manage liquids, and other detectors to allows
rapid identification of active materials, genetic modifications, and
biochemical interactions.
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/high-throughput-screening-hts-market/request-sample
Mounting demand for highly effective
therapies to cure various diseases has led to the adoption of technology in
drug discovery. Monitoring of large amount of processed data and screening are
some of the critical processes that has to be handled with high precision to
achieve required outcome. The latest trends in the drug discovery involves
formation of numerous biochemical libraries to establish set of standards and
record results, thus escalating growth of the high throughput screening (HTS)
market. Though, adoption of such procedure require specific set of skillset and
advanced software to manage and save large amount of data at high speed, lack
of which hampers growth of the high throughput screening (HTS) market.
Numerous governmental and private
agencies are assigned to monitor stringent quality checks and standards to
attain required integrity and precision for the obtained data, thus fueling
growth of the HTS market over forecast period. Yet, unavailability advanced
software to control automated instruments and liquid handling systems is
significantly hampering growth of the market. Nevertheless, one of the biggest
advantage associated with the use of the high throughput screening (HTS) is
reduction of time to formulate a drug discovery.
High Throughput Screening (HTS) is
widely known drug discovery technique, that is commonly adopted in the
pharmaceutical and healthcare sector. High throughput screening (HTS) allows
use of automation for faster examination and analysis of the biological and
chemical activities of numerous compounds that are used for production and
discovery of drugs. Application of the high throughput screening (HTS) involves
discovering molecular receptors, various enzymes, ion channels and
identification of a chemical pathway. HTS is made feasible for drug discovery
due to modern advancement in robotics and high-speed computing technique.
The market is divided into regional
market segment such as North America, Europe, Asia-Pacific, Latin America and
Africa. North America has shown major growth in recent years owing to the rise
adoption of latest methodologies in the healthcare sector for R&D purposes
and existence well-established market players in the region.
Asia-Pacific region is predicted to hold
major market share in the high throughput screening (HTS) industry with massive
growth in forecast period. Countries such as India, China and Japan are leading
the Asia-Pacific market with recent technological advancements in drug
discovery techniques with the use of 3D-cell cultures and substantial
investment by prominent industry players due to potential opportunities in the
region.
The key players in the high throughput
screening (HTS) market are Agilent Technologies Incorporations, Danaher Co.,
Thermofisher Scientific Incorporations, PerkinElmer Incorporations, Tecan Group
Limited, Hamilton Company, and Aurora Biomed Co.
For
More Details, Visit @ http://www.millioninsights.com
No comments:
Post a Comment